Tuberculosis Vaccine Development: Progress in Clinical Evaluation-Reference-Cited by-同舟云学术

Tuberculosis Vaccine Development: Progress in Clinical Evaluation

Published:2019-12-18 Issue:1 Volume:33 Page:
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Sable Suraj B.¹^ORCID,Posey James E.¹,Scriba Thomas J.²³⁴

Affiliation:

1. Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. South African Tuberculosis Vaccine Initiative, Cape Town, South Africa

3. Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa

4. Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa

Abstract

Tuberculosis (TB) is the leading killer among all infectious diseases worldwide despite extensive use of the Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. A safer and more effective vaccine than BCG is urgently required. More than a dozen TB vaccine candidates are under active evaluation in clinical trials aimed to prevent infection, disease, and recurrence.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/CMR.00100-19

Reference234 articles.

1. World Health Organization. 2018. Global tuberculosis report 2018. World Health Organization, Geneva, Switzerland. https://www.who.int/tb/publications/global_report/en/.

2. Tuberculosis

3. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

4. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

5. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mucosal vaccine formulation against tuberculosis by exploiting the adjuvant activity of S100A4—A damage-associated molecular pattern molecule;Vaccine;2024-11

2. The whole genome sequence of Polish vaccine strain Mycobacterium bovis BCG Moreau;Microbiology Spectrum;2024-07-02

3. Optimizing antigen selection for the development of tuberculosis vaccines;Cell Insight;2024-06

4. Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria;Vaccines;2024-05-12

5. Proteomics study the potential targets for Rifampicin-resistant spinal tuberculosis;Frontiers in Pharmacology;2024-04-15